✦ LIBER ✦

Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion

✍ Scribed by Hosoda, Kazuhiko ;Yokosuka, Osamu ;Kato, Naoya ;Ito, Yoshimi ;Ohto, Masao ;Omata, Masao

Publisher: Springer-Verlag
Year: 1993
Tongue: English
Weight: 257 KB
Volume: 28
Category: Article
ISSN: 0435-1339
DOI: 10.1007/bf02989220

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term carriage of hepatitis C virus

Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C

✍ Shinichi Kakumu; Kentaro Yoshika; Kazuma Tanaka; Yasuyuki Higashi; Susumu Kuroka 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

## Abstract Studies were undertaken to investigate whether interferon therapy could induce hepatitis C virus (HCV) carriage with normal serum alanine aminotransferase (ALT) values using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 53 patients

Clinical significance of hepatic HCV RNA

Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy

✍ Larghi, Alberto; Tagger, Alessandro; Crosignani, Andrea; Ribero, Maria Lisa; Bru 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-␣ (IFN-␣) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN

Long-term results of therapy with interf

Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection

✍ J. M. Durand; E. Cretel; G. Kaplanski; P. Lefevre; F. Retornaz; J. Soubeyrand 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 273 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Detection of hepatitis C virus RNA in se

Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells in patients with chronic hepatitis C treated with interferon alpha

✍ M. Basaras; B. de las Heras; M. García Bengoechea; L. Gallego; E. Arrese; R. Cis 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 316 KB

Prediction of successful outcome in a ra

Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C

✍ Vandelli, Carmen; Renzo, Francesco; Braun, Hans Bertram; Tisminetzky, Sergio; Al 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

To evaluate the efficacy of a 12-month course of recombinant interferon alpha (IFN-␣2b), and to assess predictive factors of successful response to IFN therapy in chronic active hepatitis C (HCV CAH), 242 patients with histologically proven HCV CAH were assigned randomly to two groups, one treated w